TRACY SCHOENHOFT: Open Payments
NPI 1316325475 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,641 in 72 payments from 29 companies in 2025. Trend: 2023 $1,314 · 2024 $1,218 · 2025 $1,641
Food & beverage: $1,641
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $185 |
| Janssen Biotech, Inc. | 8 | $158 |
| Novartis Pharmaceuticals Corporation | 7 | $136 |
| SANOFI-AVENTIS U.S. LLC | 5 | $107 |
| Daiichi Sankyo Inc. | 5 | $94 |
| GlaxoSmithKline, LLC. | 4 | $86 |
| Incyte Corporation | 4 | $85 |
| Cumberland Pharmaceuticals, Inc. | 3 | $62 |
| ABBVIE INC. | 2 | $62 |
| SOBI, INC | 2 | $61 |
Products named: SARCLISA, SCEMBLIX, REZUROCK, TALVEY, Vanflyta, NIKTIMVO, OJJAARA, SANCUSO.
Industry payments across OH — which companies pay providers there.
